Infectious Disease
COVID vaccine in young children – Recommendations for COVID-19 vaccines in children 6 months to 5 years
On July 14, 2022, NACI published guidance on the use of mRNA-1273 in children 6 months to 5 years. This expert brief will review the key recommendations from this guidance and discuss some of the key issues surrounding the discussion of COVID-19 vaccines in young children.
DURATION
25 min
PROFESSION
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-08-23
On July 14, 2022, NACI published guidance on the use of mRNA-1273 in children 6 months to 5 years. This expert brief will review the key recommendations from this guidance and discuss some of the key issues surrounding the discussion of COVID-19 vaccines in young children.
This program has received funding from Moderna.
Faculty
Kristen Watt, BSc, Phm, RPh
Earl Rubin, MDCM
Learning objectives
Upon completion of this continuing education video participants will be better able to:
- Discuss the current NACI COVID-19 vaccine recommendations for children 6 months to 5 years
- Describe the effectiveness data of COVID-19 vaccines in young children
- Explain the potential adverse effects and safety considerations of COVID-19 vaccines in young children